Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2012-12-12 to 2013-03-01
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- up-and-down procedure
- Limit test:
- no
Test material
- Reference substance name:
- 1-(5'-((5S)-5-(3,5-Dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'-H-spiro(azetidine-3,1'-(2)benzofuran)-1-yl)-2-(methylsulfonyl)ethanone
- Cas Number:
- 1398609-39-6
- Molecular formula:
- C23H18Cl2F4N2O5S
- IUPAC Name:
- 1-(5'-((5S)-5-(3,5-Dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'-H-spiro(azetidine-3,1'-(2)benzofuran)-1-yl)-2-(methylsulfonyl)ethanone
Constituent 1
- Specific details on test material used for the study:
- Lot No.: PF-06450567-GLK
Purity: Not provided
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Texas Animal Specialties; Humble, TX
- Females nulliparous and non-pregnant: yes
- Age at study initiation: Ca. 9-10 weeks
- Weight at study initiation: 157-200 g
- Fasting period before study: approximately 16 hours before dosing
- Housing: Suspended stainless steel with wire bottom, 1 per cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23
- Humidity (%): 28-97
- Air changes (per hr): > 10 air changes per hour
- Photoperiod (hrs dark / hrs light): 12-hour light/dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- The test article was mixed with CMC and Tween 80 in Deionized water to produce a 10% w/v concentration. An individual dose was calculated for each animal based on its fasted body weight and administered by gavage at a volume ranging from 0.55 mL/kg at the 55 mg/kg level to 20.0 mL/kg at the 2000 mg/kg level. Each dose was administered using an appropriately sized syringe and stainless steel ball-tipped intubation needle. Animals were returned to their cages immediately after dosing.
- Doses:
- 55, 175, 550 and 2000 mg/kg
- No. of animals per sex per dose:
- one for 55 &175 mg/kg; 2 for 550 mg/kg, 4 for 2000 mg/kg
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Observations for mortality and clinical/behavioral signs of toxicity were made at least three times on the day of dosing (day 0) and at least once daily thereafter for 14 days. Individual body weights were recorded just prior to dosing and on days 7 and 14, or at time of discovery after death.
- Necropsy of survivors performed: yes, On day 14 after dosing, each surviving animal was euthanized by an overdose of CO2. All study animals were subjected to gross necropsy and all abnormalities recorded. - Statistics:
- The LD50 value with 95% confidence interval was calculated using the AOT425 Stat Program supplied by EPA.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 783 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 550 - < 2 000
- Mortality:
- Mortality occurred only at the 2000 mg/kg level (4/4).
- Clinical signs:
- other: Clinical signs in one survivor included activity decrease, emaciation, decreased/no defecation, small/hard feces, piloerection, sensitivity to touch and staggered gait, on Days 3-9. Animals that died on test exhibited activity decrease, body tremors, crus
- Gross pathology:
- Gross necropsy on animals that died on test revealed stained fur and under tail; crusted muzzle; discolored lungs and liver; gas in stomach; and empty gastrointestinal tract. Gross necropsy on animals surviving to termination revealed no observable abnormalities.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The acute oral LD50 for test item is estimated to be 783 mg/kg in female rats.
- Executive summary:
Test article was evaluated for its acute oral toxicity potential in female albino rats when administered as a gavage dose by OECD 425. A main test was conducted following up-and-down procedure (UDP) at 55, 175, 550 and 2000 mg/kg. The study was terminated following stopping rules of this procedure.
Mortality occurred only at the 2000 mg/kg level. Clinical signs in one survivor included activity decrease, emaciation, decreased/no defecation, small/hard feces, piloerection, sensitivity to touch and staggered gait, on Days 3-9. Animals that died on test exhibited activity decrease, body tremors, crusted face, piloerection and small feces. Animals surviving to termination exhibited weekly weight gain, except for two that lost or failed to gain weight between days 0 and 7. Abnormal necropsy findings that occurred, only in the animals dying on test, pertained to fur, muzzle/tail areas, lungs, liver and contents of the stomach/intestines.
The acute oral LD50 was estimated to be 783 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.